Velan Posts $15.1M Q2 Loss as Sales Slide 15% to $57.5M

Velan Inc. (TSX: VLN) reported a net loss of $15.1 million, or $0.70 per share, for its second quarter ended August 31, 2026, on sales of $57.5 million, the industrial valve manufacturer announced on October 7, 2026. The Montreal-based company's quarterly sales fell 15% from $67.6 million a year earlier, while gross margin compressed to 21.9% from 23.2%. Transaction-related costs of $14.9 million tied to a June change-of-control transaction drove the loss. Adjusted net loss, which excludes those costs, was $6.2 million, or $0.29 per share.

Context — Why Velan's Q2 Miss Matters Now

The quarter's headline loss is largely an accounting event rather than an operational collapse. On June 15, 2026, controlling shareholder Velan Holding Co. Ltd. closed the sale of its controlling interest in the company, triggering conditional fees that Velan was obligated to pay. That obligation produced the $14.9 million transaction charge booked in the quarter, against just $0.7 million in transaction costs a year earlier. The company said the charge reflects "significant one-time transaction costs rather than a change in the underlying business," according to CFO Imran Gibbons.

Stripping out that charge, Velan still lost $6.2 million on an adjusted basis, compared with an adjusted net loss of $1.2 million in the same quarter last year. That gap is operational. Sales fell because production timing shifted shipments into later periods, and the company cited uncertainty around changing tariff regulations and ongoing geopolitical tension as drags on customer demand and order timing.

The macro backdrop compounds the pressure. Velan's core end-markets — nuclear, defense, power and process industries — carry long project cycles, so a single quarter of delayed deliveries can swing revenue materially. The company also operates manufacturing across three continents, exposing cross-border shipments to tariff costs that management said weighed on gross profit this quarter.

What changed to trigger the reporting event is the ownership transition itself. The new controlling shareholder structure closed in June, and with it came a new $80 million revolving credit facility maturing in June 2031. Velan used proceeds to repay its Canadian secured bank loan in full during the quarter and to fund the transaction costs. That reshaped the balance sheet from net cash of $41.5 million at February 28, 2026 to negative $11.2 million net cash at August 31, 2026.

Data — What the Numbers Show

The quarter's decline was broad. Sales of $57.5 million compared with $67.6 million a year earlier, a drop of $10.1 million, or 15.0%. Gross profit fell to $12.6 million from $15.7 million, with the margin contraction reflecting lower absorption of fixed production overhead, the net impact of tariffs on cross-border shipments, and a less favorable project mix — partially offset by a favorable reversal of aged inventory provisions at Asian operations.

Administration costs rose to $16.9 million, or 29.4% of sales, from $15.4 million, or 22.7% of sales, driven mainly by higher engineering and R&D spending. The percentage jump largely reflects the smaller sales base.

Metric	Q2 FY2027	Q2 FY2026
Sales	$57.5M	$67.6M
Gross margin	21.9%	23.2%
Net loss	$15.1M	$1.7M
Adjusted EBITDA	-$0.7M	$3.4M
Backlog	$262.5M	$285.8M

Backlog stood at $262.5 million at August 31, 2026, down from $283.3 million at February 28, 2026 and $285.8 million a year earlier. Bookings totaled $47.9 million in the quarter, down from $65.2 million a year earlier, reflecting weaker order intake in North American nuclear, power and process end-markets and continued softness in China, partly offset by resilient maintenance, repair and overhaul activity.

Over six months, sales fell 17.5% to $115.4 million, gross margin dropped to 20.8% from 26.0%, and the net loss reached $24.5 million, or $1.14 per share, versus net income of $16.2 million a year earlier. Last year's figure included a $58.6 million gain from discontinued operations tied to the disposal of French assets.

Analysis — What It Means for Markets and Sectors

Velan's exposure runs through industrial capital spending, not consumer demand. Weaker nuclear and power order intake in North America signals that large project awards are being deferred, which matters for the broader valve and flow-control supply chain and for engineering, procurement and construction firms tied to the same end-markets. The company said demand in its core nuclear, defense and energy markets "remains solid," attributing the softness to execution, delivery timing and tariff volatility rather than a demand collapse.

MRO activity is the counterweight. The company said MRO represented a significant share of total bookings in the quarter and remained comparatively resilient — the aftermarket tends to hold up better than new-build orders when capital budgets tighten. That mix shift, if it persists, supports revenue stability but at lower margins than large project work.

The clearest risk is the balance sheet. Negative $11.2 million net cash, against positive $41.5 million just six months earlier, leaves less cushion. Velan drew $39.9 million on its new $80 million facility and reported available borrowing capacity of $66.2 million at August 31, 2026. Combined with $28.2 million in cash and $1.4 million in short-term investments, total available liquidity was $95.8 million. The company said it remains in compliance with all debt covenants.

A counter-argument worth weighing: the backlog decline was partly a function of shipments converting to revenue, not purely cancellations. About 76% of backlog, or $200.1 million, is slated for delivery within twelve months — a shorter-duration mix that supports near-term revenue but leaves less visibility beyond the coming year. Currency moves added $0.3 million to backlog value in the first half on euro strength.

Positioning-wise, the stock's story now hinges on whether the transformation plan converts into bookings. Velan launched six pillars — cost discipline, procurement and value engineering, talent, manufacturing footprint, working capital and growth acceleration — aimed at what CEO Rishi Sharma called building "a leaner company" and driving profitable growth.

Outlook — What to Watch Next

The immediate catalyst is the restructuring plan. Subsequent to August 31, 2026, Velan implemented workforce reductions affecting corporate activities. Because the action came after the reporting date, no provision was recorded in the quarter; management estimates restructuring costs of roughly $2 million to $3 million, to be recognized in the next reporting period.

The dividend is gone for now. The board, citing the restructuring plan and liquidity preservation, determined the company would not pay a dividend for the remainder of fiscal 2027, and will re-evaluate the policy annually. Income-focused holders face a changed proposition.

Next on the calendar is the second-quarter conference call on Thursday, October 8, 2026, at 8:00 a.m. EDT, with a replay available until October 15, 2026. Management said a number of larger opportunities in core end-markets are in the pipeline at varying stages of qualification, with a portion expected to convert in the near term. Whether bookings recover toward the prior year's $65.2 million quarterly pace is the metric that matters.

Frequently Asked Questions

Why did Velan report such a large net loss this quarter?

The $15.1 million net loss was driven mainly by $14.9 million in transaction-related costs tied to the June 15, 2026 closing of the change-of-control transaction, which created an obligation for Velan to pay conditional fees. Excluding those costs, the adjusted net loss was $6.2 million, or $0.29 per share, reflecting lower sales and gross profit rather than the one-time charge.